The Latest
Treatment for Severe Malaria Gets Breakthrough Therapy Status
Investigational Treatment for Hypereosinophilic Syndrome Granted Orphan Drug Status
Skyrizi Approved for Moderate to Severe Plaque Psoriasis
Fremanezumab Cluster Headache Development Program Discontinued
Risks, Benefits of Long-Term Drug Therapy for Osteoporosis Reviewed
Los Angeles County Measles Outbreak Under Investigation
USPSTF Urges Asymptomatic Bacteriuria Screen in Pregnancy
KardioMobile Device Gets FDA Clearance for Bradycardia, Tachycardia Detection
FDA Approves Novel Non-Surgical Device for Weight Reduction in Obese Patients
MPR ARTICLES
